Portugal Spain France Iceland UK Ireland Belgium Netherlands Germany Denmark Norway Finland Sweden Switzerland Italy Austria Czech Republik Slovakia Croatia Poland Hungary Romania Greece Lithuania Latvia Estonia Belarus Ukraina Serbia & Montenegro Bulgaria Moldavia Macedonia Albania

Biotechnology and Pharma Switzerland

Biotechnology and Pharma Germany

Biotechnology and Pharma Sweden

Biotechnology and Pharma   UK

Biotechnology and Pharma  Ireland

Biotechnology and Pharma  France

Biotechnology and Pharma Italy

Biotechnology and Pharma Netherlands

Biotechnology and Pharma Belgium

Biotechnology and Pharma Norway

Biotechnology and Pharma Denmark

Biotechnology and Pharma  Austria

Biotechnology and Pharma  Greece

Biotechnology and Pharma Finland

Biotechnology and Pharma Spain

Biotechnology and Pharma Hungary

Biotechnology and Pharma Russia

Biotechnology and Pharma Czech Republic

Biotechnology and Pharma Estonia

Biotechnology and Pharma Poland

Biotechnology and Pharma Portugal

Biotechnology and Pharma  Slovakia

Biotechnology and Pharma Lithuania

Biotechnology and Pharma  Iceland

Biotechnology and Pharma Slovenia

Biotechnology and Pharma Bulgaria

Biotechnology and Pharma Romania

Biotechnologyand Pharma Macedonia

Biotechnology and Pharma Albania

Biotechnology and Pharma Luxembourg

Biotechnology and Pharma Serbia

Biotechnology and Pharma Cyprus

Biotechnology and Pharma Malta

Biotechnology and Pharma Belarus

Biotechnology and Pharma Croatia

Biotechnology and Pharma Ukraina

Biotechnology and Pharma Turkey

 

 
 

New compound offers attractive therapeutic candidate for autoimmune inflammatory diseases

 

A new way to increase the numbers of mobilized stem cells

 

New Microneedle Applicator Device

 

Novel compound offers new treatment approach for ovarian cancer

 

A diagnostic marker for early cancer detection

 
  Sulidin® nimesulide LPS Non-Steroidal Topical Anti-inflammatory gel for the local treatment of painful inflammatory conditions
 

 
29.08.2008 Oxford Biomedica plc Unaudited Interim Results for the Six Months Ended 30 June 2008
 
26.08.2008 ADAGIO trial results show Azilect® slows progression of Parkinson's disease
 
25.08.2008 Cell Therapeutics, Inc. Announces Reverse Stock Split
 
22.08.2008 FDA Approves NplateTM for Long-Term Treatment of Adult Chronic ITP
 
20.08.2008 JAMA Publishes Study Results on Efficacy of the Bard Agento(R) I.C. Silver-Coated Endotracheal Tube in Preventing Ventilator-Associated Pneumonia
 
20.08.2008 Avantogen Ltd Receives Commitment of $1M in a Private Placement
 
19.08.2008 BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
 
19.08.2008 European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
 
15.08.2008 Evidence of activity seen in new data from ASA404 prostate cancer trial
 
13.08.2008 MOLOGEN AG publishes results for the first half-year of 2008
 
13.08.2008 Genentech Special Committee of Independent Directors Responds to Roche Proposal